Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
Date:8/11/2008

XI'AN, China, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it has signed a major supply agreement with DNP International Co., Inc. of Santa Fe Springs, CA.

Under the terms of the agreement Huifeng is to deliver 62 metric tons of Glucuronolactone, a naturally occurring chemical compound which has become a popular additive to energy drinks, over the next six months to DNP. The total dollar amount of the contract is in excess of USD $1.1 Million.

Huifeng anticipates signing additional bi-annual contracts with DNP upon successful completion of the first agreement.

''Our agreement with DNP further demonstrates the increasing international acceptance of Huifeng products. With quality and consistency as our hallmarks, we are now becoming recognized by major US corporations for the quality and consistency of the products we develop and manufacture,'' stated company CEO Jing'An Wang. ''We are pleased to be making further inroads into the US market and hope to sign similar supply agreements with DNP and other US entities in the near future.''

About Glucuronolactone

Glucuronolactone is a naturally occurring chemical compound produced by the metabolism of glucose in the human liver. It is an important structural component of nearly all connective tissues. The most common usage for Glucuronolactone is in many energy drinks. Because most of these drinks also contain caffeine, Glucuronolactone is included because it is purported to fight fatigue and provide a sense of well-being. According to "The Merck Index" (14th edition) it is also used as detoxicant. (From Wikipedia)

About DNP International

DNP International imports and distributes raw material ingredients to manufacturers in the nutritional supplements, food, beverage, feed, cosmetics and pharmaceutical industries. Founded in 1994, DNP is one of the largest suppliers of raw materials in the United States and sources over 2,500 different ingredients. http://www.dnpint.com/

About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/

For more information, please contact:

Dan Carlson,

Primary Capital LLC

Email: DCarlson@PrimaryLLC.com

Kelly Black, CEO

Premier Media Services, Inc.

Tel: +1-480-649-8224


'/>"/>
SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
2. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status
3. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
4. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
5. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
6. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
7. Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
8. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
9. Sentry Enhances Offerings with Temperature-Controlled Custom Bio-Pharmaceutical Finishing Services
10. Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
11. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... Ca (PRWEB) , ... July 25, 2017 , ... ... specialty converted media and software solutions that enable short-run digital printing, is proud ... Chemical Labels and its free GHS Wizard online software available at avery.com/GHS ...
(Date:7/26/2017)... MA (PRWEB) , ... July 26, 2017 , ... ... a variety of complex problems we face every day. This unique capability ... researchers, agronomists, geologists, chemists, and manufacturers to deliver unprecedented datasets for chemical analysis, ...
(Date:7/25/2017)... ... July 25, 2017 , ... Fiberstar, Inc ., a global market leader ... 125. This natural citrus fiber is used to improve tomato-based food products by replacing ... condiments and spreads. Today, more than ever, consumers connect ingredients to the foods they ...
(Date:7/24/2017)... ... July 24, 2017 , ... Each year, Inavero’s ... have proven their superior service quality as rated by hiring professionals and job ... leader based on service quality ratings from their placed talent. , Fewer than ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):